Spire Healthcare Group PLC (LON:SPI) is scheduled to be announcing its earnings results on Wednesday, September 13th.

Shares of Spire Healthcare Group PLC (SPI) opened at 319.90 on Tuesday. The firm has a 50-day moving average of GBX 334.12 and a 200-day moving average of GBX 334.18. The company’s market capitalization is GBX 1.28 billion. Spire Healthcare Group PLC has a one year low of GBX 297.50 and a one year high of GBX 411.00.

ILLEGAL ACTIVITY NOTICE: This piece of content was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/12/spire-healthcare-group-plc-spi-to-release-quarterly-earnings-on-wednesday.html.

Several research firms have commented on SPI. Numis Securities Ltd reiterated an “add” rating and issued a GBX 375 ($4.84) price objective on shares of Spire Healthcare Group PLC in a report on Wednesday, July 26th. Liberum Capital cut their price objective on shares of Spire Healthcare Group PLC from GBX 365 ($4.71) to GBX 350 ($4.52) and set a “hold” rating for the company in a research report on Thursday, August 31st. Jefferies Group LLC upped their price objective on shares of Spire Healthcare Group PLC from GBX 305 ($3.94) to GBX 350 ($4.52) and gave the stock a “hold” rating in a research report on Thursday, June 1st. Berenberg Bank upped their price objective on shares of Spire Healthcare Group PLC from GBX 360 ($4.65) to GBX 390 ($5.04) and gave the stock a “buy” rating in a research report on Wednesday, June 21st. Finally, Credit Suisse Group reaffirmed an “underperform” rating on shares of Spire Healthcare Group PLC in a research report on Friday, July 21st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of GBX 355.86 ($4.60).

Spire Healthcare Group PLC Company Profile

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Receive News & Stock Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related stocks with our FREE daily email newsletter.